SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 119 filers reported holding SUTRO BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $76,860 | -12.9% | 22,150 | +16.7% | 0.00% | – |
| Q2 2023 | $88,266 | +24.5% | 18,982 | +23.7% | 0.00% | – |
| Q1 2023 | $70,908 | -34.9% | 15,348 | +13.9% | 0.00% | – |
| Q4 2022 | $108,870 | +87.7% | 13,474 | +29.7% | 0.00% | – |
| Q3 2022 | $58,000 | -73.5% | 10,392 | -61.0% | 0.00% | – |
| Q1 2022 | $219,000 | -61.0% | 26,632 | -29.5% | 0.00% | – |
| Q4 2021 | $562,000 | -54.9% | 37,769 | -42.7% | 0.00% | -100.0% |
| Q3 2021 | $1,246,000 | -1.2% | 65,942 | -2.8% | 0.00% | 0.0% |
| Q2 2021 | $1,261,000 | – | 67,809 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |